44OCCTG IND.231: A phase 1 trial evaluating CX-5461 in patients with advanced solid tumors. (5th March 2018) - Hilton, J; Cescon, D W; Bedard, P; Ritter, H; Tu, D; Soong, J; Gelmon, K; Aparicio, S; Seymour, L